[COVID-19] Govt should not hesitate to invoke compulsory licensing of drugs under Patent Act if necessary: Delhi High Court

The Court nonetheless said that the "best course" would be to "encourage" the existing manufacturers to ramp up their production on a war footing, as was done in the case of Remdesivir, and to grant "voluntary licenses"
[COVID-19] Govt should not hesitate to invoke compulsory licensing of drugs under Patent Act if necessary: Delhi High Court
Compulsory license

The Central government should, if necessary, invoke its powers under the Patent Act to direct compulsory licensing of the drugs to deal with the COVID-19 situation, the Delhi High Court said on Tuesday in view of the shortage of several drugs that are used for saving the lives of COVID-19 patients (Rakesh Malhotra vs GNCTD).

Want to read the full story?

We’re glad you’re enjoying this story. Subscribe to any of our plans to continue reading the story.

Already have an account? Sign In

Related Stories

No stories found.
Bar and Bench - Indian Legal news
www.barandbench.com